Androgen receptors beyond prostate cancer: an old marker as a new target

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Androgen receptors (ARs) are crucial in prostate cancer development and treatment.
• Evidence suggests ARs are involved in other cancer types, but this is under-explored.
• Hormonal manipulation targeting ARs has shown significant benefits in prostate cancer.

Purpose of the Study:

• To review AR expression patterns across a wide range of cancers.
• To explore the therapeutic potential of targeting ARs in non-prostate malignancies.
• To highlight the clinical implications of AR signaling in diverse tumor types.

Main Methods:

• Literature review of studies on AR expression in various cancers.
• Analysis of existing data on the role of ARs in cancer pathogenesis and progression.
• Synthesis of information regarding the clinical efficacy of AR-targeted therapies.

Main Results:

• ARs are expressed in a diverse spectrum of human cancers beyond prostate cancer.
• AR signaling pathways are implicated in the growth and progression of these diverse tumors.
• Preclinical and clinical data suggest potential efficacy of AR-targeted agents in other cancers.

Conclusions:

• Androgen receptor targeting is a validated therapeutic strategy for prostate cancer.
• AR expression and function in other cancers warrant further investigation.
• Exploiting AR pathways offers a promising avenue for novel cancer therapies across multiple tumor types.